3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Radiosurgery
4
pazopanib
2
atezolizumab
2
Nivolumab
2
Drug Therapy
2
trastuzumab deruxtecan
1
pembrolizumab
1
osimertinib
1
montanide ISA 51
1
durvalumab
1
cobimetinib
1
cemiplimab
1
avelumab
1
alectinib
1
Transurethral Resection of Prostate
1
Surveys and Questionnaires
1
Specimen Handling
1
Sodium Chloride
1
Radiotherapy
1
Patient-Specific Modeling
1
Oncolytic Virotherapy
1
Observation
1
Nicotine Replacement Therapy
1
National Cancer Institute (U.S.)
1
Motivational Interviewing
1
Microscopy, Electron
1
Memantine
1
Magnetic Resonance Spectroscopy
1
MLN 8237
1
Interleukin-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
Patient-Specific Modeling
×
Dermatologic
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn